Label-Free Detection Market Worth 2,292.0 Million USD By 2022
The Global Label Free Detection Market will grow at a CAGR of 8.8% from 2017 to 2022 to reach USD 2,292.0 million by 2022, according to the latest publication from Meticulous Research®. The global label free detection market is driven by rapid growth in pharmaceutical and biotechnology market, increasing adoption of innovative approaches in drug discovery, and rising initiatives & funding for various R&D activities. Moreover, emerging economies such as Asia-Pacific and Latin America provides significant opportunities in this market. However, high cost of instruments and shortage of skilled professionals for handling of complex equipment inhibits the growth of the market to some extent.
The global label free
detection market is mainly segmented by product (consumables and instruments),
technology (surface plasmon resonance, bio-layer interferometry, cellular
dielectric spectroscopy, electrical impedance spectroscopy, optical
waveguidegrating technology, and others), application (binding kinetics, hit
confirmation, lead generation, endogenous receptor detection, binding
thermodynamics, and others), end user (pharmaceutical & biotechnology
industry, academic and research institutes, contract research organization, and
others), and geography.
Browse
in-depth Report on https://www.meticulousresearch.com/product/label-free-detection-market-forecast-2022/
Based on product type,
consumables held the largest share of the market in 2016 and expected to
continue its dominance in the global label free detection market during the
forecast period, owing to their increasing adoption for screening of
biomolecules and assays for accurate and easy diagnosis of disease and to
understand the interaction of these assays with target molecules for drug
discovery application.
Based on technology,
surface plasmon resonance accounted for the major share of the global label free
detection market in 2016, owing to its wide applications and compatibility with
all types of biomolecules
On the basis of
application, binding kinetics held the largest share of the global label free
detection market in 2016. This is mainly attributed to the growing need to
diagnose the molecular and cellular binding properties between various
biomolecules for drug discovery.
Based on end users,
pharmaceutical and biotechnology industry commanded the largest share in 2016
due to rising adoption of label free technologies in the drug discovery and
development and preclinical studies for the analysis of binding kinetics of the
target molecules, pharmacodynamics, and toxicology.
Geographically, this
market is segmented into North America (U.S. and Canada), Europe (Germany,
France, Italy, Spain, U.K., Turkey, and RoE), Asia Pacific (China, India,
Japan, Indonesia, South Korea, and RoAPAC), Latin America, and Middle East
& Africa. North America commanded the largest share in the global label
free detection market in 2016, followed by Europe and Asia-Pacific. The large
share of this market is mainly attributed to the well-established healthcare
system in the region, higher acceptance of advanced technologies, availability
of funds for research from various public and private sector organizations,
growing prevalence of non-communicable diseases & related rise in
pharmaceutical research & development, and presence of many key players in
this market
Speak-To-Analyst
:https://www.meticulousresearch.com/speak-to-analyst/?cp_id=3408
Global Label Free
Detection Market, By Geography, 2017-2022
However, Asia Pacific and
Latin American regions are expected to witness significant growth during the
forecast period due to rising R&D expenditure, increasing pharmaceutical
research outsourcing in the region owing to lower cost advantages, rising
government funding, and improving healthcare infrastructure. In addition,
significantly growing pharmaceutical industry in Asia primarily due to huge
demand for medical care from large population base with increasing incidence
& prevalence of chronic disease and aging population in the region are
expected to further support the growth of label free detection market in the
region.
The key players operating
in the global label free detection market are GE Healthcare (U.S.), Corning
Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation
(U.S.), Bio-Rad Laboratories, Inc. (U.S.), AMETEK, Inc.(U.S.), BiOptix Inc.
(U.S.), Horiba, Ltd. (Japan), BioNavis Limited (Finland), PerkinElmer Inc.
(U.S.), and Attana AB (Sweden). These vendors employed various strategies to
expand their product and application offerings, global footprint, and augment
their market share. The key strategies followed by most companies in the global
label free detection market were new product developments, collaborations &
partnerships, acquisitions, and expansions.
Download-Sample-Report: https://www.meticulousresearch.com/download-sample-report/?cp_id=3408
About Meticulous Research®
Meticulous Research® is
founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in
2013 as a private limited company under the Companies Act, 1956. Since its
incorporation, the company has become the leading provider of premium market
intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle
East & Africa.
Viren
Shrivastava
AVP- Global Sales and Marketing
Meticulous Research®
Tel: +1-646-781-8004
Comments
Post a Comment